Intelligent Bio Solutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INBS and other ETFs, options, and stocks.

About INBS

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. 

CEO
Harry Simeonidis
CEOHarry Simeonidis
Employees
55
Employees55
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2016
Founded2016
Employees
55
Employees55

INBS Key Statistics

Market cap
11.77M
Market cap11.77M
Price-Earnings ratio
-0.57
Price-Earnings ratio-0.57
Dividend yield
Dividend yield
Average volume
1.03M
Average volume1.03M
High today
$10.42
High today$10.42
Low today
$8.85
Low today$8.85
Open price
$9.93
Open price$9.93
Volume
372.21K
Volume372.21K
52 Week high
$27.50
52 Week high$27.50
52 Week low
$4.03
52 Week low$4.03

Stock Snapshot

Intelligent Bio Solutions(INBS) stock is priced at $9.72, giving the company a market capitalization of 11.77M. It carries a P/E multiple of -0.57.

During the trading session on 2026-01-23, Intelligent Bio Solutions(INBS) shares reached a daily high of $10.42 and a low of $8.85. At a current price of $9.72, the stock is +9.8% higher than the low and still -6.7% under the high.

Trading activity shows a volume of 372.21K, compared to an average daily volume of 1.03M.

The stock's 52-week range extends from a low of $4.03 to a high of $27.50.

The stock's 52-week range extends from a low of $4.03 to a high of $27.50.

People also own

Based on the portfolios of people who own INBS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.